How have VICP shares performed in 2024?

Vicapsys Life Sciences' stock was trading at $2.74 at the beginning of the year. Since then, VICP shares have decreased by 64.6% and is now trading at $0.9699. View the best growth stocks for 2024 here .

How do I buy shares of Vicapsys Life Sciences?

Shares of VICP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:VICP

Vicapsys Life Sciences (VICP) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free VICP Stock Alerts

$0.97

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $0.97
▼
$0.97
50-Day Range: $0.97
▼
$2.25
52-Week Range: $0.60
▼
$3.00

Volume: N/A
Average Volume: 179 shs
Market Capitalization: $31.10 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings

Get Vicapsys Life Sciences alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About Vicapsys Life Sciences Stock (OTCMKTS:VICP)

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Cumming, Georgia.

VICP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VICP Stock News Headlines

November 4, 2023 | morningstar.com

Anavex Life Sciences Corp AVXL

August 9, 2023 | finance.yahoo.com

VICP - Vicapsys Life Sciences, Inc.

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

July 3, 2023 | msn.com

ViCapsys files for Nasdaq uplisting, $8M public offering

February 19, 2023 | benzinga.com

Global Life Science Tools Strategic Business Report 2023: Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects

September 29, 2022 | finance.yahoo.com

ViCapsys Life Sciences Appoints Three New Board Members

April 18, 2022 | finance.yahoo.com

ViCapsys Life Sciences Appoints Federico Pier as Permanent Chief Executive Officer

See More Headlines

Receive VICP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Construction
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:VICP
CUSIP: N/A
CIK: 1468639
Web: vicapsys.com
Phone: (972) 891-8033
Fax: N/A
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-990,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -598.80%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.13
Quick Ratio: 0.13

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.03) per share
Price / Book: -32.33

Miscellaneous

Outstanding Shares: 32,070,000
Free Float: 30,153,000
Market Cap: $31.10 million
Optionable: Not Optionable
Beta: -6.02

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Federico Pier (Age 56)
CEO, Executive Chairman & Interim President
Comp: $120k
Mr. Jeffery Wright CPA (Age 41)
CPA, Chief Financial Officer
Comp: $90k
Dr. Mark C. Poznansky M.D.
Ph.D., Chief Scientist Advisor & Founder

Key Competitors

View All Competitors

VICP Stock Analysis - Frequently Asked Questions

How have VICP shares performed in 2024?: Vicapsys Life Sciences' stock was trading at $2.74 at the beginning of the year. Since then, VICP shares have decreased by 64.6% and is now trading at $0.9699.
View the best growth stocks for 2024 here.
How do I buy shares of Vicapsys Life Sciences?: Shares of VICP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VICP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial